Health care resource use and direct medical costs for patients with schizophrenia in Tianjin, People’s Republic of China
Jing Wu,1 Xiaoning He,1 Li Liu,2 Wenyu Ye,2 William Montgomery,3 Haibo Xue,2 Jeffery S McCombs41School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, People’s Republic of China; 2Lilly Suzhou Pharmaceutical Company, Ltd, Shanghai, People’s Republic of Chi...
Guardado en:
Autores principales: | Wu J, He XN, Liu L, Ye W, Montgomery W, Xue HB, McCombs JS |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/994b8b9fe6ee499f97fdede25ff38b19 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The cost reduction in hospitalization associated with paliperidone palmitate in the People’s Republic of China, Korea, and Malaysia
por: Chiou CF, et al.
Publicado: (2015) -
Medication use patterns, health care resource utilization, and economic burden for patients with major depressive disorder in Beijing, People’s Republic of China
por: Zhang L, et al.
Publicado: (2016) -
Systematic review of the prevalence and incidence of Parkinson’s disease in the People’s Republic of China
por: Zou YM, et al.
Publicado: (2015) -
High relapse rate and poor medication adherence in the Chinese population with schizophrenia: results from an observational survey in the People’s Republic of China
por: Xiao JB, et al.
Publicado: (2015) -
Investigation on Internet addiction disorder in adolescents in Anhui, People’s Republic of China
por: Chen Y, et al.
Publicado: (2016)